Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Mammalian target of rapamycin and head and neck squamous cell carcinoma Liao YM; Kim C; Yen YHead Neck Oncol 2011[Apr]; 3 (ä): 22Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.|Animals[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Carcinoma, Squamous Cell[MESH]|Carcinoma/drug therapy/*etiology/genetics[MESH]|Head and Neck Neoplasms/drug therapy/*etiology/genetics[MESH]|Humans[MESH]|Models, Biological[MESH]|Neoplasms, Squamous Cell/drug therapy/*etiology/genetics[MESH]|Protein Kinase Inhibitors/therapeutic use[MESH]|Signal Transduction/drug effects/genetics/physiology[MESH]|Squamous Cell Carcinoma of Head and Neck[MESH]|TOR Serine-Threonine Kinases/antagonists & inhibitors/genetics/*physiology[MESH] |